IMMU

Immunomedics, Inc. News Headlines

$3.96
*  
0.03
 negative 
0.75%
Get IMMU Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Immunomedics to Ring Opening Bell and Host R&D Day at the NASDAQ Stock Market
4/10/2014 8:30:00 AM - GlobeNewswire

Immunomedics Reports Preclinical Results on SN-38 Antibody-Drug Conjugates as a Potential Novel Platform for Treating Cancer
4/8/2014 8:30:00 AM - GlobeNewswire

Immunomedics Reports Results From Three Phase I Trials With IMMU-130 in Metastatic Colorectal Cancer
4/7/2014 11:01:00 AM - GlobeNewswire

Immunomedics Announces Multiple Partial Responses With IMMU-132 in Solid Cancers
4/7/2014 11:00:00 AM - GlobeNewswire

Immunomedics to Provide Clinical Trial Updates on Solid-Tumor Antibody-Drug Conjugates at Cancer Conference
3/31/2014 8:30:00 AM - GlobeNewswire

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Immunomedics, Inc.
3/28/2014 9:52:00 AM - Business Wire

Lifshitz & Miller Law Firm Announces Investigation of CytRx Corporation, DURECT Corporation, Hastings Entertainment, Inc., Immunomedics, Inc. and NII Holdings, Inc.
3/18/2014 4:01:00 PM - PR Newswire

Attention Immunomedics, Inc. Investors: Immunomedics Misled Investors According to a Recently Filed Class Action
3/6/2014 5:24:00 PM - PR Newswire

Investor Alert: Pittsburgh Law Office of Alfred G. Yates, Jr., P.C. Announces Investigations into Carnival Corporation (NYSE: CCL), Emeritus Corp. (ESC), FedEx Corporation (FDX), Forest Laboratories (FRX), Immunomedics (IMMU), JPMorgan Chase & Co. (JPM),
3/5/2014 12:21:00 PM - PR Newswire

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. -- IMMU
3/3/2014 3:00:00 PM - GlobeNewswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics, Inc. - IMMU
2/28/2014 9:55:00 AM - PR Newswire

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Immunomedics, Inc.
2/27/2014 11:33:00 AM - Business Wire

Immunomedics Extends Patent Life on Therapeutic Antibodies
2/26/2014 11:13:00 AM - GlobeNewswire

Immunomedics to Present at Cowen and Company 34th Annual Health Care Conference
2/26/2014 8:30:00 AM - GlobeNewswire

Immunomedics Announces Second Quarter Fiscal 2014 Results and Clinical Program Developments
2/10/2014 4:01:00 PM - GlobeNewswire

Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2014 Financial Results
2/6/2014 5:19:00 PM - GlobeNewswire

Immunomedics Ranks 4th in the Patent Board Biotechnology Industry Scorecard
2/4/2014 1:15:00 PM - GlobeNewswire

Investor Alert: Immunomedics, Inc. Investigation Announced by Holzer & Holzer, LLC
1/27/2014 11:50:00 AM - Business Wire